Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Slooter, A.J. C.
Right arrow Articles by van Duijn, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Slooter, A.J. C.
Right arrow Articles by van Duijn, C. M.
Related Collections
Right arrow All Cerebrovascular disease/Stroke
Right arrow All Cognitive Disorders/Dementia
Right arrow All epidemiology
Right arrow Risk factors in epidemiology
Right arrow Infarction
NEUROLOGY 2004;62:1196-1198
© 2004 American Academy of Neurology
Brief Communications

The impact of APOE on myocardial infarction, stroke, and dementia

The Rotterdam Study A.J. C. Slooter, MD PhD, M. Cruts, PhD, A. Hofman, MD PhD, P. J. Koudstaal, MD PhD, D. van der Kuip, MD PhD, M.A. J. de Ridder, MSc, J.C. M. Witteman, PhD, M.M. B. Breteler, MD PhD, C. Van Broeckhoven, PhD and C. M. van Duijn, PhD

From the Departments of Epidemiology & Biostatistics (Drs. Slooter, Hofman, van der Kuip, Witteman, Breteler, and van Duijn, and M.A.J. de Ridder) and Neurology (Dr. Koudstaal), Erasmus Medical Center, Rotterdam, the Netherlands; Molecular Genetics Laboratory (Drs. Cruts and Van Broeckhoven), Flanders Interuniversity Institute for Biotechnology (VIB), Born-Bunge Foundation (BBS), Department of Biochemistry, University of Antwerp (UIA), Antwerpen, Belgium; and Rudolf Magnus Institute of Neurosciences (Dr. Slooter), Department of Neurology, University Medical Center, Utrecht, the Netherlands.

Address correspondence and reprint requests to Dr. Cornelia M. van Duijn, Department of Epidemiology & Biostatistics, Erasmus Medical Center, PO Box 1738, 3000 DR Rotterdam, the Netherlands; e-mail: c.vanduijn{at}erasmusmc.nl

It is unclear how the APOE genotype contributes to the incidence of vascular diseases and dementia. In a population-based sample (n = 6,852) with complete follow-up, APOE was weakly associated with myocardial infarction and not related with stroke. In the absence of {epsilon}4, the incidence of dementia would be 25.8% lower; in the absence of {epsilon}2/{epsilon}3, 2.8% higher. Risk estimates of dementia, specified for age, sex, and APOE, are provided for counseling. APOE is not strongly related to vascular diseases, but contributes substantially to dementia incidence.

Received April 5, 2003. Accepted in final form November 13, 2003.




This article has been cited by other articles:


Home page
 JAMAHome page
J. Attia, J. P. A. Ioannidis, A. Thakkinstian, M. McEvoy, R. J. Scott, C. Minelli, J. Thompson, C. Infante-Rivard, and G. Guyatt
How to Use an Article About Genetic Association: C: What Are the Results and Will They Help Me in Caring for My Patients?
JAMA, January 21, 2009; 301(3): 304 - 308.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
J. Attia, J. P. A. Ioannidis, A. Thakkinstian, M. McEvoy, R. J. Scott, C. Minelli, J. Thompson, C. Infante-Rivard, and G. Guyatt
How to Use an Article About Genetic Association: B: Are the Results of the Study Valid?
JAMA, January 14, 2009; 301(2): 191 - 197.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
A. M. Bennet, E. Di Angelantonio, Z. Ye, F. Wensley, A. Dahlin, A. Ahlbom, B. Keavney, R. Collins, B. Wiman, U. de Faire, et al.
Association of Apolipoprotein E Genotypes With Lipid Levels and Coronary Risk
JAMA, September 19, 2007; 298(11): 1300 - 1311.
[Abstract] [Full Text] [PDF]

Home page
 J Gerontol A Biol Sci Med SciHome page
D. C. Ewbank
Differences in the Association Between Apolipoprotein E Genotype and Mortality Across Populations
J Gerontol A Biol Sci Med Sci, August 1, 2007; 62(8): 899 - 907.
[Abstract] [Full Text] [PDF]

Home page
 Mayo Clin Proc.Home page
D. S. Knopman
Dementia and Cerebrovascular Disease
Mayo Clin. Proc., February 1, 2006; 81(2): 223 - 230.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
E. J. Heyer, D. A. Wilson, D. H. Sahlein, J. Mocco, S. C. Williams, R. Sciacca, A. Rampersad, R. J. Komotar, J. Zurica, A. Benvenisty, et al.
APOE-{varepsilon}4 predisposes to cognitive dysfunction following uncomplicated carotid endarterectomy
Neurology, December 13, 2005; 65(11): 1759 - 1763.
[Abstract] [Full Text] [PDF]